Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to investigate how the cable-driven arm exoskeleton (CAREX) can assist task performance during 3D arm movement tasks under various experimental conditions in healthy individuals and patients with stroke. This study is designed to test motor learning with the robotic rehabilitative device CAREX under three conditions in healthy subjects and subjects with post-stroke hemiparesis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Healthy Subjects | Active Comparator | Seven healthy patients will serve as controls based on preliminary data in healthy volunteers using CAREX with gravity elimination alone versus gravity elimination plus path assistance. |
|
| Chronic Post Stroke Right Side Hemiparesis | Active Comparator | Radiologically verified unilateral stroke patients with at least 4 months previously. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Gravity Elimination Alone | Other | CAREX will compensate for the gravity of the subject's arm, i.e. subject can move their arm to a specific position and relax all the arm muscles, CAREX will hold the arm in that configuration |
| Measure | Description | Time Frame |
|---|---|---|
| Passive range of motion measured by goniometry | 1 Day | |
| Active range of motion measured by goniometry | 1 Day | |
| Upper extremity motor impairment measured by performance on the 33 tasks of the Fugl-Meyer Scale (FMS) | 1 Day | |
| Spasticity measured by the Modified Ashworth Scale (MAS) | 1 Day |
Not provided
Not provided
Inclusion Criteria for stroke population:
Exclusion Criteria for stroke population.
Inclusion Criteria for control population.
Exclusion Criteria for control population.
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Preeti Raghavan, MD | New York University Medical School | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| New York University School of Medicine | New York | New York | 10016 | United States |
Not provided
| ID | Term |
|---|---|
| D020521 | Stroke |
| ID | Term |
|---|---|
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Path Assistance Alone | Other | CAREX will push subject's arm to a pre-specified path. If the arm is not in the path, CAREX will generate some force that is proportional to the distance between the hand and the path. The subject will feel like having a spring connected between his hand and the path |
|
| Path Assistance and Gravity Elimination | Other |
|
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |